Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Oct 27, 2022

VBI Ratings Not as Impressive As We Would Have Liked in 2022
Image: How the VBI rating system has ranked equities so far this year. At Valuentum, we use the Valuentum Buying Index (VBI) to source ideas into diversified simulated newsletter portfolios, and the VBI may be most applicable to the simulated Best Ideas Newsletter portfolio, where we generally like to include ideas when they register a high VBI rating and remove them when they register a low VBI rating. We always use the VBI in a portfolio setting and never by itself. Let's talk more about the VBI rating system in this work.

Oct 27, 2022

Honeywell Jumps on Third-Quarter Report, Strong Guidance
Image Source: Honeywell. On October 27, Dividend Growth Newsletter portfolio holding Honeywell International reported solid third-quarter performance and provided higher guidance for the full-year 2022. We continue to like the company as an idea in the simulated Dividend Growth Newsletter portfolio, as we expect robust dividend growth in the coming years. The high end of our fair value estimate of Honeywell stands at $224 per share. Shares yield ~2.2% at the time of this writing.

Oct 24, 2022

Chip Stocks -- Geopolitical Uncertainty Heightens in China; ASML, QCOM Still Strong Long-Term Considerations, But Expect Near-Term Fundamental Weakness
Image Source: The U.S. Department of Commerce. The global economic environment continues to reel from heightened inflation, which is pressuring consumer discretionary spending, but geopolitical uncertainty remains at a fever pitch. Russia’s invasion of Ukraine has unsettled investors, but the back-and-forth between the U.S. and China has chipmakers in the crosshairs. On October 7, 2022, the U.S. Department of Commerce released a report aimed to restrict China’s ability to attain advanced computer chip technology. We expect a downward revision to our fair value estimates across the chip space, but many of their refreshed fair value estimates will remain within their existing fair value estimate ranges. We expect a downward revision to our fair value estimates across the chip space, but many of their refreshed fair value estimates will remain within their existing fair value estimate ranges. Qualcomm will report fourth-quarter results November 2, 2022, and we’ll have more to say after the report. We recently dove into ASML’s quarterly report for the period ending October 3, which wasn’t too bad. Of note, ASML indicated that the export restrictions won’t be as punitive for them as many believe given its headquarters in the Netherlands. Though our newsletter portfolio "exposure" to the chip space is small, we'll be watching fundamental performance across the group closely.

Oct 21, 2022

Dividend Increases/Decreases for the Week of October 21
Let's take a look at firms raising/lowering their dividends this week.

Oct 20, 2022

Philip Morris Is One of Our Favorite High-Yielding Income Generation Ideas
Image Shown: Philip Morris International Inc expects alternative nicotine products will grow at a robust pace over the coming years, with an eye towards heated tobacco units and oral nicotine products. By capitalizing on those opportunities, the company aims to diversify its revenues away from traditional cigarette sales. Image Source: Philip Morris International Inc – 2021 Investor Day Event Presentation. Philip Morris is a strong cash flow generator with ample pricing power and a bright growth outlook. Underlying demand for its IQOS heated tobacco offerings remains robust and demand for its traditional cigarette offerings is holding up well, even in the face of substantial inflationary pressures weighing negatively on consumer spending power around the global. Philip Morris’ near term guidance indicates that it should remain a strong free cash flow generator in 2022, allowing the firm to stay on top of its payout obligations. Management remains committed to rewarding income seeking shareholders, and we continue to like exposure to shares of Philip Morris in our High Yield Dividend Newsletter portfolio.

Oct 19, 2022

Johnson & Johnson Reports Mixed 3Q Results, Plans to Spin Off Consumer Health Division Mid-to-Late 2023
Image Source: Johnson & Johnson. Johnson & Johnson is one of the top weightings in the simulated Dividend Growth Newsletter portfolio, and it has delivered tremendous stability at a time when the markets are facing considerable pressure. Year-to-date, Johnson & Johnson has fallen about 4% on a price-only basis, while the S&P 500 is down more than 18% so far in 2022. Macroeconomic uncertainty, inflationary pressures and currency headwinds will muddy operational results in the near term, and its planned spin-off of its ‘Consumer Health’ division as Kenvue in mid-to-late 2023 will complicate financials, but we still like Johnson & Johnson. Shares yield ~2.7% at the time of this writing.

Oct 18, 2022

Dividend Growth Newsletter Portfolio Idea Lockheed Martin Continues to Power Ahead in 3Q 2022, Showcases Strong 3% Dividend Yield
Image Source: Tomas Del Coro. Lockheed Martin recently raised its quarterly dividend rate to $3 per share, and the stock now boasts a ~3% dividend yield, which we like a lot. As it relates to all of 2022, Lockheed Martin is targeting an impressive $6+ billion in free cash flow, which helps support our fair value estimate range of $313-$495 per share (with emphasis on the high end) and its resilient Dividend Cushion ratio of 1.4. We’re sticking with shares of Lockheed Martin in the simulated Dividend Growth Newsletter portfolio at this time.

Oct 18, 2022

BIN Portfolio ALERT: Removing META, Adding to XLE, Adding MCD and PEP
Image Source: Valuentum. This market is not going to get easier, in our view, and we still believe that 2023 may mark the bottom before a return to the path toward new highs again. However, the erratic volatile trading the past few weeks has us thinking that this is not a market focused on fundamentals, and therefore, we have to hedge our bets accordingly. With “alpha” otherwise we would have missed carved out by "raising" cash in late August before the latest swoon, we’ll now approach newsletter portfolio protection with put option considerations going forward. The changes made today will be reflected in the November 15 edition of the Best Ideas Newsletter. Please let us know if you have any questions.

Oct 18, 2022

Dividend Growth Idea UnitedHealth Group Outperforming
Image Shown: Shares of dividend growth idea UnitedHealth Group Inc have put up stellar performance so far in 2022. We are huge fans of UnitedHealth Group, and its dividend growth potential remains immense. The top end of our fair value estimate range sits at $599 per share of UnitedHealth Group, indicating that the health care giant also possesses substantial capital appreciation upside as well. UnitedHealth Group’s acquisition of Change Healthcare is intriguing and should generate material synergies going forward. Looking ahead, we expect that UnitedHealth Group will grow its dividend at a robust pace, aided by its strong free cash flow generating abilities and pristine balance sheet.

Oct 16, 2022

The Valuentum Learning Center
Image Source: Gaby Av. Learn about investing, Valuentum's investment process and more!